Agenda 2024
Agenda - Friday, October 11, 2024
*Times listed are in Eastern Standard Time
6:45 - 7:30 AM |
Registration and Breakfast with Exhibits |
|
7:20 - 7:30 AM |
Welcome and Introductions |
|
7:40 - 8:55 AM |
SESSION I |
|
7:40 - 7:50 AM |
Imaging of the Conduction System to Guide Pacing |
|
7:50 - 8:00 AM |
LBBP for CRT: Conduction System Capture is Essential for Success |
|
8:00 - 8:10 AM |
Effect of Scar on Conduction System Pacing |
|
8:10 - 8:20 AM |
RAFT PERM AF: CRT in AF Patients? |
|
8:20 - 8:30 AM |
Innovation, Research Gaps, and Promise for Advances in VT/Sudden Cardiac Death |
|
8:30 - 8:55 AM |
Panel Discussion with Q&A Session |
|
8:55 - 10:05 AM |
SESSION II |
|
8:55 - 9:05 AM |
Role of CMR to Evaluate Ablation Success and RF Lesion Evolution |
|
9:05 - 9:15 AM |
From Image to Intervention: Streamlining VT Ablation with Multimodality Imaging |
|
9:15 - 9:25 AM |
Predicting Ventricular Tachycardia Circuits in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy using Genotype-Specific Heart Digital Twins ) |
|
9:25 - 9:35 AM |
MRI Guided Preventive Treatment of VT Substrates in CHD: Towards Cure? |
|
9:35 - 9:45 AM |
Intracardiac Ultrasound for Titrating Radiofrequency Energy |
|
9:45 - 10:05 AM |
Panel Discussion with Q&A Session |
|
10:05 – 10:25 AM |
Break and Visit Exhibits |
|
10:25 - 11:35 AM |
SESSION III |
|
10:25 - 10:35 AM |
Basic Mechanisms of Ventricular Arrhythmias – the Tissue is the Issue |
|
10:35 - 10:45 AM |
Unipolar dV/dt as a Unique Marker of Arrhythmogenic Myocardium |
|
10:45 - 10:55 AM |
The Spatial Ventricular Gradient and VT inducibility |
|
10:55 - 11:05 AM |
Evolving Understanding of Inflammation in VT/PVC Management |
|
11:05 - 11:15 AM |
Structural Abnormalities of Papillary Muscles and Relation to Focal VAs |
|
11:15 - 11:35 AM |
Panel Discussion with Q&A Session |
|
11:35 – 11:45 AM |
Pick-Up Lunch in Exhibit Hall |
|
11:45 AM - 1:30 PM |
SESSION IV The Mount Sinai Hospital ∙ New York, NY Hospital of University of Pennsylvania ∙ Philadelphia, PA |
|
1:35 – 2:45 PM |
SESSION V |
|
1:35 - 1:45 PM |
Role of Artificial Intelligence in SCD Risk Stratification |
|
1:45 - 1:55 PM |
Role of ICDs in the Contemporary Era of HF GDMT |
|
1:55 - 2:05 PM |
Risk Stratification in Mitral Valve Prolapse |
|
2:05 - 2:15 PM |
Machine Learning Insights into LQTS and Brugada Syndrome |
|
2:15 - 2:25 PM |
Risk Stratification in Sarcoidosis |
|
2:25 - 2:45 PM |
Panel Discussion with Q&A Session |
|
2:50 - 4:00 PM |
SESSION VI |
|
2:50 - 3:00 PM |
Advancements in Catheter Ablation for J Wave Syndrome |
|
3:00 - 3:10 PM |
Substrates of Unexplained SCD/IVF Delineated by Arrhythmia Characteristics |
|
3:10 - 3:20 PM |
Ablation Strategies to Targeting the VF Substrate |
|
3:20 - 3:30 PM |
Epicardial Ablation of Brugada Syndrome: Who are the right patients? |
|
3:30 - 3:40 PM |
Inherited Arrhythmias: From Mechanism to Molecular Therapies |
|
3:40 - 4:00 PM |
Panel Discussion with Q&A Session |
|
4:00 – 4:20 PM |
Break and Visit Exhibits |
|
4:20 - 5:50 PM |
SESSION VII |
|
4:20 - 4:30 PM |
FDA Perspective on VT Trials |
|
4:30 - 4:40 PM |
LESS-VT: Emerging Data |
|
4:40 - 4:50 PM |
Cryocure-VT: One-year results & Next Steps |
|
4:50 - 5:00 PM |
EMAP Trial |
|
|
Forthcoming Trials – Rapid Fire Presentations |
|
5:00 - 5:05 PM |
Magnetic VT |
|
5:05 - 5:10 PM |
FACILE-VT |
|
5:10 - 5:15 PM |
RADIATE-VT |
|
5:15 - 5:20 PM |
Sphere-9 VT |
|
5:20 - 5:50 PM |
Panel Discussion with Q&A Session |
|
6:00 - 7:30 PM |
Welcome Reception in Exhibit Hall with Abstract Posters |